Breaking News

Sartorius Partners with Nova Biomedical

Firms combine ambr technology with the BioProfile FLEX2

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sartorius Stedim Biotech (SSB) has formed an agreement with Nova Biomedical (www.novabiomedical.com), a U.S. manufacturer of cell culture analyzers, to integrate their BioProfile FLEX2 into the ambr multi-parallel bioreactor systems for automated, at-line cell culture analytics. SSB and Nova are collaborating to combine two innovative technologies. Both the BioProfile FLEX2 analyzer and the parallel bioprocessing functionality of the ambr create a tool able to simultaneously run, sample and anal...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters